Global ?-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
According to our (Global Info Research) latest study, the global ?-Nicotinamide Mononucleotide (NMN) market size was valued at USD 264.1 million in 2022 and is forecast to a readjusted size of USD 330.5 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, etc. Asia-Pacific is the largest producer of beta-nicotinamide mononucleotide (NMN), holds a share about 65%, followed by North America, and Europe . In terms of purity, content greater than or equal to 98% is the largest segment, with a share over 90%. And in terms of application, the largest segment is health care products, with a share over 90%.
This report is a detailed and comprehensive analysis for global ?-Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global ?-Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global ?-Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global ?-Nicotinamide Mononucleotide (NMN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global ?-Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ?-Nicotinamide Mononucleotide (NMN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global ?-Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical and Maac10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
?-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Purity ?98%
    Purity ?98%
Market segment by Application
    Health Care Products
    Cosmetics
    Others
Major players covered
    GeneHarbor
    Herbalmax
    Genex Formulas
    Shinkowa Pharmaceutical
    Maac10 Formulas
    Bontac
    Shandong Sihuan Pharmaceutical
    EffePharm
    Zhejiang Jiahua Pharmchemical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe ?-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of ?-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of ?-Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the ?-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ?-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and ?-Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of ?-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe ?-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.